Matt Sagan

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

October, 2024

Matt Sagan

Oct 23, 2024, 14:45 | Blog

Paolo Tarantino: How do we build a new generation of safer and more active ADCs for treating cancer

Paolo Tarantino and Raffaele Colombo shared posts on X, about recent paper published in Cancer…

Jun 7, 2024, 02:21 | Insight

Matt Sagan: Is HER2-negative breast cancer really negative?

Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post on X: "Is HER2-negative breast cancer really…

Jun 4, 2024, 10:52 | Insight

Matt Sagan: Innovative approach of HER2 expression quantitative assessment using inPROBE technology

Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post on X: “Innovative fiber optic–based…

Jun 4, 2024, 10:02 | Insight

Matt Sagan: President Biden and Jill Biden set two clear goals for the Biden Cancer Moonshot initiative

Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post by ASCO on X, adding:…

May 11, 2024, 11:23 | Insight

Matt Sagan: Moving from HER2+ to HER2-low to HER2- ultralow

Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post by Paolo Tarantino on X,…

All: 5 Posts: 1 - 100

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Lyda Hill Philanthropies Was Honored with the American Cancer Society Philanthropist of the Year Award

Why President Biden Values Cancer Research So Much: The Story Behind Cancer Moonshot

The 2024 NIH Director’s Awards

Tedros Adhanom Ghebreyesus Received 2024 Rebranding Africa Forum Governance Leadership Award

Special Coverage

ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023